MMMajid Mokhtari

Majid Mokhtari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Majid Mokhtari has a total of 202 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Taheri

    Institute of Human Genetics, Jena University Hospital, Jena, Germany; Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    13 shared publications
  • Soudeh Ghafouri-Fard

    Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    11 shared publications
  • Bashdar Mahmud Hussen

    Department of Clinical Analysis, College of Pharmacy Hawler Medical University Erbil Iraq

    10 shared publications
  • Mohammad Sistanizad

    Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    9 shared publications
  • Maryam Farasatinasab

    Department of Clinical Pharmacy and Pharmacoeconomics, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.

    6 shared publications
  • Mehran Kouchek

    Shahid Beheshti Univ Med Sci, Imam Hossein Med & Educ Ctr, Dept Crit Care Med, Tehran, Iran

    6 shared publications

Latest Publications

  • Open Access

    The Impact of Olfactory Dysfunction on Post-operative Cognitive Dysfunction and Delirium: A Systematic Review

    by Mahdi Amirdosara, Mohammadreza Hajiesmaeili, Reza Goharani, Majid Mokhtari, Ali Vafaei, Masood Zangi

    Context: Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) are common complications following major surgery, particularly in older adults. Emerging evidence suggests that olfactory dysfunction may significantly predispose individuals to these cognitive disturbances, potentially serving as an early marker for post-surgical cognitive decline. However, the relationship between olfactory impairment and post-operative cognitive outcomes remains underexplored. Objectives: The present systematic review aims to synthesize current evidence on the impact of olfactory dysfunction on POCD and POD. Evidence Acquisition: The review adhered to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. A comprehensive search of PubMed, Scopus, and the Web of Science (WOS) was conducted from inception until December 2024. Studies on patients undergoing major operations that involved verified olfactory and cognitive examinations and yielded quantitative data were included. Exclusion criteria encompassed research focusing on non-surgical groups, non-original studies, and studies lacking postoperative cognitive assessments. Results: From an initial 389 articles, seven studies met the inclusion criteria, comprising 1,038 participants. These studies, conducted between 2004 and 2022, included patients undergoing major surgeries such as cardiac, abdominal, and neurosurgery. Various olfactory tests [e.g., sniffin’ sticks, brief smell identification test (BSIT)] and cognitive assessments [e.g., mini-mental state examination (MMSE), clock drawing test (CDT)] were used. The findings across studies were heterogeneous but suggested a potential link between olfactory dysfunction and both POCD and POD. Specifically, several studies indicated that impaired olfactory function was associated with an increased risk of delirium (OR = 1.90; 95% CI = 1.17 - 3.09) and cognitive decline post-surgery. Some studies identified olfactory impairment as an independent predictor of worse cognitive outcomes, particularly among frail or elderly populations. Conclusions: The evidence reviewed supports the hypothesis that olfactory dysfunction may be a preoperative marker for POCD, particularly delirium and delayed neurocognitive recovery (dNCR). Based on the obtained results, olfactory testing could be a useful preoperative screening tool, especially in populations at risk for cognitive decline.

  • Open Access

    Enhanced Recovery After Surgery (ERAS) Protocol for Craniotomy Patients: A Systematic Review

    by Masood Zangi, Mahsa Asadi Anar, Mahdi Amirdosara, Majid Mokhtari, Reza Goharani, Sara Sanei Moghaddam, Omidvar Rezaei, Seyede Hamideh Hashemiyazdi, Mohammadreza Hajiesmaeili

    Context: The enhanced recovery after surgery (ERAS) protocol is a multidisciplinary approach aimed at improving surgical outcomes, reducing complications, minimizing hospital stays, and lowering healthcare costs. Objectives: This study assesses the impact of the ERAS protocol on elective craniotomies, a routine procedure in neurosurgery. Methods: A comprehensive search across PubMed, Embase, Scopus, and Web of Science identified 562 articles. Following strict screening criteria, 54 studies were reviewed, and ultimately 10 studies meeting the inclusion criteria were selected for detailed analysis. Results: The review encompassed ten studies [one prospective, one systematic review, and eight randomized controlled trials (RCTs)] published between 2016 and 2023. Key components of the ERAS protocol included preoperative counseling, high-protein intestinal nutrition, preoperative fasting while avoiding carbohydrate intake within 2 hours of surgery, standardized anesthetic and analgesic regimens, and early postoperative initiation of enteral feeding. Postoperative outcomes showed fewer complications, early mobilization, and notably shorter hospital stays, all of which contributed to improved patient recovery. Conclusions: This review demonstrates that the ERAS protocol, when applied to elective craniotomies, is effective in enhancing postoperative recovery, improving functional outcomes, and reducing hospitalization duration.


  • Open Access

    A concise review on the role of MIR100HG in human disorders

    by Soudeh Ghafouri‐Fard, Atefeh Harsij, Hossein Farahzadi, Bashdar Mahmud Hussen, Mohammad Taheri, Majid Mokhtari

    MIR100HG is a long non‐coding RNA (lncRNA) encoded by a locus on chr11:122,028,203‐122,556,721. This gene can regulate cell proliferation, apoptosis, cell cycle transition and cell differentiation. MIR100HG was firstly identified through a transcriptome analysis and found to regulate differentiation of human neural stem cells. It is functionally related with a number of signalling pathways such as TGF‐β, Wnt, Hippo and ERK/MAPK signalling pathways. Dysregulation of MIR100HG has been detected in a diversity of cancers in association with clinical outcomes. Moreover, it has a role in the pathophysiology of dilated cardiomyopathy, intervertebral disk degeneration and pulmonary fibrosis. The current study summarizes the role of these lncRNAs in human disorders.


  • Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms

    by Soudeh Ghafouri-Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri, Majid Mokhtari


  • A review on the role of ADAMTS9-AS2 in different disorders

    by Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Aria Baniahmad, Mohammad Taheri, Majid Mokhtari


  • Deciphering the role of Hippo pathway in lung cancer

    by Soudeh Ghafouri-Fard, Yadollah Poornajaf, Bashdar Mahmud Hussen, Shiva Tavakkoli Avval, Mohammad Taheri, Majid Mokhtari


  • Open Access

    Exosomal circular RNA: a signature for lung cancer progression

    by Bashdar Mahmud Hussen, Snur Rasool Abdullah, Goran Sedeeq Hama Faraj, Mohammed Fatih Rasul, Abbas Salihi, Soudeh Ghafouri-Fard, Mohammad Taheri, Majid Mokhtari

    Membrane vesicles having a diameter of 30–150 nm are known as exosomes. Several cancer types secrete exosomes, which may contain proteins, circular RNAs (circRNAs), microRNAs, or DNA. CircRNAs are endogenous RNAs that do not code for proteins and can create continuous and covalently closed loops. In cancer pathogenesis, especially metastasis, exosomal circRNAs (exo-circRNAs) have a crucial role mainly due to the frequently aberrant expression levels within tumors. However, neither the activities nor the regulatory mechanisms of exo-circRNAs in advancing lung cancer (LC) are obvious. A better understanding of the regulation and network connections of exo-circRNAs will lead to better treatment for LCs. The main objective of the current review is to highlight the functions and mechanisms of exo-circRNAs in LC and assess the relationships between exo-circRNA dysregulation and LC progression. In addition, underline the possible therapeutic targets based on exo-circRNA modulating.


  • Open Access

    A long non-coding RNA with important roles in the carcinogenesis

    by Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Mohammad Taheri, Majid Mokhtari

    Long non-coding RNAs are demonstrated to contribute to carcinogenesis. TMPO Antisense RNA 1 (TMPO-AS1) is an example of lncRNAs with crucial roles in this process. This lncRNA serves as a sponge for miR-320a, miR-383-5p, miR-329-3p, miR-126, miR-329, miR‐199a‐5p, miR-577, miR-4731-5p, miR-140-5p, miR-1179, miR-143-3p, miR-326, miR-383-5p, let-7c-5p, let-7g-5p, miR-199a-5p, miR-200c, miR-204-3p, miR-126-5p, miR-383-5p, miR-498, miR-143-3p, miR-98-5p, miR-140 and miR-143. It can also affect activity of PI3K/Akt/mTOR pathway. The current review summarizes the role of TMPO-AS1 in the carcinogenesis and assessment of its potential as a marker for certain types of cancers.


  • A review on the role of PCGEM1 lncRNA in cancer

    by Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Aria Baniahmad, Mohammad Taheri, Majid Mokhtari


  • Open Access

    A review on the role of LINC01133 in cancers

    by Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri, Majid Mokhtari

    Long Intergenic Non-Protein Coding RNA 1133 (LINC01133) is a long non-coding RNA (lncRNA) which interacts with miR-106a-3p, miR-576-5p, miR-495-3p, miR-205, miR-199a-5p, miR-4784, miR-30a-5p, miR-199a, miR-30b-5p, miR-216a -5p and miR-422a, thus increasing expression of mRNA targets of these miRNAs. LINC01133 can affect cancer metastasis through regulation of epithelial-mesenchymal transition program. Dysregulation of this lncRNA has been repeatedly detected in the process of tumorigenesis. In this review, we summarize the results of various studies that reported dysregulation of LINC01133 in different samples and described the role of this lncRNA as a marker for these disorders.